Study to Evaluate the Efficacy and Safety of IN-B00009 Injection in Adults With Obesity or Overweight Without Diabetes Mellitus

NCT07192263 · clinicaltrials.gov ↗

PHASE3

Phase

NOT_YET_RECRUITING

Status

300

Enrollment

INDUSTRY

Sponsor class

Conditions

Obesity &Amp; Overweight

Interventions

DRUG: IN-B00009
DRUG: Placebo

Sponsor

HK inno.N Corporation